Your browser doesn't support javascript.
loading
Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial.
Backlund, Ellen; Yang, Muyi; Grozman, Vitali; Masucci, Giuseppe; Falkenius, Johan; Eriksson, Hanna; Jovanovic, Braslav; Hammarlund, Katarina; Isacsson, Ulf; Radu, Calin; Abel, Edvard; Karlsson, Kristin; Palanco Zamora, Ricardo; Wersäll, Peter; Edbäck, Ulrika; Wickström, Stina; Darai Ramqvist, Eva; Egyhazi Brage, Suzanne; Kiessling, Rolf; Viktorsson, Kristina; Franzén, Bo; Lewensohn, Rolf; Olofsson Bagge, Roger; Ullenhag, Gustav J; Ny, Lars; Lindberg, Karin; Helgadottir, Hildur.
  • Backlund E; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
  • Yang M; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Grozman V; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Masucci G; Department of Diagnostic Radiology, Karolinska University Hospital, Sweden.
  • Falkenius J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Eriksson H; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Jovanovic B; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Hammarlund K; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
  • Isacsson U; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Radu C; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Abel E; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
  • Karlsson K; Medical Radiation Physics, Uppsala University Hospital, Uppsala, Sweden.
  • Palanco Zamora R; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Wersäll P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Edbäck U; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Wickström S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Darai Ramqvist E; Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Egyhazi Brage S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Kiessling R; Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Viktorsson K; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
  • Franzén B; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Lewensohn R; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Olofsson Bagge R; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Ullenhag GJ; Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.
  • Ny L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Lindberg K; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Helgadottir H; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Acta Oncol ; 61(7): 869-873, 2022 07.
Article en En | MEDLINE | ID: mdl-35638255
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Melanoma Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Melanoma Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article